Trust Company’s VanEck Biotech ETF BBH Stock Holding History

Trust Company’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-34,782	Closed	-$4.33M	–	353
2017 Q4	$4.33M	Buy	34,782 +34,357	+8,084%	+$4.39M	1.79%	18
2017 Q3	$57K	Hold	425	–	–	0.03%	133
2017 Q2	$53K	Hold	425	–	–	0.02%	155
2017 Q1	$51K	Hold	425	–	–	0.02%	179
2016 Q4	$46K	Hold	425	–	–	0.02%	179
2016 Q3	$49K	Hold	425	–	–	0.02%	180
2016 Q2	$43K	Buy	+425	New	+$45.3K	0.02%	183

Other funds holding BBH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Trust Company's BBH Position: Q1 2018 in Review

Trust Company sold out of VanEck Biotech ETF (BBH) in Q1 2018, closing a stake of 34,782 shares — an estimated $4.33M sold.

Trust Company first reported a position in BBH in Q2 2016 and held it in 7 quarters. The position peaked at $4.33M in Q4 2017. 82 funds tracked by Wall St. Rank hold BBH as of Q1 2018.

Trust Company reported no remaining VanEck Biotech ETF position as of Q1 2018 after selling out during the quarter.
Trust Company sold 34,782 VanEck Biotech ETF shares in Q1 2018, an estimated $4.33M.
Trust Company first reported a position in VanEck Biotech ETF in Q2 2016 and held it in 7 quarters.
Trust Company's VanEck Biotech ETF position peaked at $4.33M in Q4 2017.
82 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2018.

Based on Trust Company's 13F filing for Q1 2018, filed 9 Apr 2018.